###begin article-title 0
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes
###end article-title 0
###begin p 1
Conceived and designed the experiments: US IN MB AT. Performed the experiments: IN MB. Analyzed the data: IN. Contributed reagents/materials/analysis tools: MB. Wrote the paper: US IN. Other: Reviewed and edited the paper: AT
###end p 1
###begin p 2
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 174 180 <span type="species:ncbi:10090">murine</span>
###xml 326 331 <span type="species:ncbi:9606">human</span>
###xml 757 762 <span type="species:ncbi:10090">Mouse</span>
###xml 943 948 <span type="species:ncbi:9606">human</span>
###xml 1288 1293 <span type="species:ncbi:9606">human</span>
###xml 1730 1735 <span type="species:ncbi:9606">human</span>
The characteristics of human resistin (RETN) are unclear and controversial despite intensive adipose-focused research. Its transcriptional and functional similarity with the murine myeloid-specific and CCAAT/enhancer binding protein epsilon (Cebpe)-dependent gene, resistin-like gamma (Retnlg), is unexplored. We examined the human CEBPE-regulatory pathway by unbiased reference and custom gene expression assays. Real-time RT-PCR analysis demonstrated lack of both the transcriptional factor CEBPE and RETN expression in adipose and muscle cells. In contrast, primary myelocytic samples revealed a concerted CEBPE-RETN transcription that was significantly elevated in inflammatory synoviocytes relative to intact peripheral blood mononuclear cells (PBMC). Mouse Cebpe and Retnlg were predictably expressed in macrophages, whereas Retn was abundant in adipocytes. Quite the opposite, a low and inconsistent RETN transcription was seen in some human white adipose tissue (WAT) biopsies without any relationship to body mass index, insulin sensitivity, or fat depot. However, in these cases, RETN was co-detected with CEBPE and the leukocyte-specific marker, EMR1, indicating the presence of inflammatory cells and their possible resistin-mediated effect on adipocytes. Indeed, addition of human resistin to WAT in culture induced, like in PBMC, the inflammatory cytokines IL6, IL8 and TNF. Importantly, the expression of the adipose-specific markers CEBPA, FABP4 and SLC2A4 was unchanged, while the expected inhibitory effect was seen with TNF. Both cytokines increased the mRNA level of CCL2 and MMP3, which may further promote inflammation in WAT. Thus, the myeloid-restricted nature of CEBPE precludes the expression of RETN in human adipocytes which, however, are targeted by this innate immune-derived proinflammatory cytokine.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 135 138 <span type="species:ncbi:9606">man</span>
###xml 461 466 <span type="species:ncbi:10090">mouse</span>
###xml 477 482 <span type="species:ncbi:9606">human</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 836 841 <span type="species:ncbi:9606">human</span>
###xml 873 878 <span type="species:ncbi:9606">human</span>
Obesity is clearly associated with the development of insulin resistance, diabetes and other metabolic and cardiovascular disorders in man. An important mechanistic link between these debilitating diseases and an increased fat mass is thought to be the anomalous production by adipose cells of a group of diverse effector molecules, collectively named adipocytokines. Like many other assumptions, this hormonal or endocrine hypothesis was primarily explored in mouse, although human genome and physiology significantly diverge from the rodent settings. Recently, mouse resistin was described as a novel obesity-mediated adipocytokine that impairs glucose homeostasis by affecting both insulin-stimulated glucose uptake in adipose tissue and hepatic glucose production during fasting. However, there were initially two opposite views on human resistin. Like in rodents, the human homolog appears as an adipose-specific and obesity-regulated antagonist of insulin action or, conversely, blood/immune cells and not adipocytes are source of resistin.
###end p 4
###begin p 5
###xml 43 50 43 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t001">Table 1</xref>
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Holcomb1">[1]</xref>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 307 310 307 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Kim1">[2]</xref>
###xml 408 414 408 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 414 417 414 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Steppan1">[3]</xref>
###xml 564 567 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Holcomb1">[1]</xref>
###xml 569 572 569 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Steppan2">[4]</xref>
###xml 651 654 651 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Gerstmayer1">[5]</xref>
###xml 656 659 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Schinke1">[6]</xref>
###xml 744 751 744 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t001">Table 1</xref>
###xml 812 815 812 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Holcomb1">[1]</xref>
###xml 816 819 816 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Steppan1">[3]</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 173 178 <span type="species:ncbi:9606">human</span>
###xml 248 254 <span type="species:ncbi:10090">murine</span>
###xml 323 329 <span type="species:ncbi:10090">murine</span>
###xml 476 481 <span type="species:ncbi:10090">mouse</span>
###xml 692 697 <span type="species:ncbi:9606">human</span>
###xml 850 856 <span type="species:ncbi:10090">murine</span>
###xml 920 925 <span type="species:ncbi:9606">human</span>
Mouse resistin, official gene symbol Retn (Table 1), is also known under other aliases depending on how it has been identified. Holcomb et al.[1] discovered mouse Fizz3 and human FIZZ3 by searching sequence databases for genes similar to the novel murine gene Fizz1, found in inflammatory zone 1. Kim et al.[2] named a new murine protein as solely adipose tissue-specific secretory factor (ADSF) and Steppan et al.[3] called it resistin for causing resistance to insulin. The mouse resistin like alpha (Retnla) and beta (Retnlb) genes were also known at that time [1], [4], while one additional gene, resistin like gamma (Retnlg), was described later [5], [6]. So far, only two corresponding human genetic traits have been variably recognized (Table 1), but registered as RETN and RETNLB. These original reports [1]-[3] concordantly highlighted that murine resistin is produced entirely by adipocytes, but the source of human resistin remained unknown.
###end p 5
###begin p 6
###xml 145 148 145 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Kubota1">[7]</xref>
###xml 422 425 422 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov1">[8]</xref>
###xml 506 509 506 509 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ten</underline>
###xml 510 511 510 511 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</underline>
###xml 519 520 519 520 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</underline>
###xml 622 629 622 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t001">Table 1</xref>
###xml 675 687 675 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 1015 1018 1015 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Nagaev1">[9]</xref>
###xml 1307 1311 1307 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Savage1">[10]</xref>
###xml 1313 1317 1313 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Janke1">[11]</xref>
###xml 1408 1411 1408 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Nagaev1">[9]</xref>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 675 687 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 843 848 <span type="species:ncbi:9606">human</span>
###xml 886 892 <span type="species:ncbi:10090">murine</span>
###xml 1404 1407 <span type="species:ncbi:9606">man</span>
As frequently happens, the clarification came from another field. The earliest annotation of the mouse Retnlg was provided in accession BE847001 [7]. This novel gene for short cysteine-rich protein 1 (homologous to FIZZ1) was not expressed in myeloid cells from C/EBP-epsilon knockout mice. The myeloid-specific nuclear transcription factor CCAAT/enhancer binding protein epsilon (CEBPE) has been characterized previously [8]. The same group also identified all resistin-related genes, which were named as ten-cysteine-proteins (XCP) for their characteristic C-terminal stretch of 10 cysteine residues with equal spacing (Table 1). Resistin (RETN) was defined in AF352730 as Homo sapiens C/EBP-epsilon regulated myeloid-specific secreted cysteine-rich protein precursor (HXCP1) gene. These findings as well as the broadly accepted belief that human resistin, RETN, is homologous to the murine counterpart Retn were tested in our earlier study of the putative role of RETN as a factor involved in insulin resistance [9]. We showed that RETN was readily expressed in monocytes. However, RETN mRNA levels were low and unstably detected in WAT while RETN transcript was totally absent in isolated adipocytes and muscle samples from non-obese euglycemic but insulin-resistant subjects. Therefore we, like others [10], [11], concluded that resistin in WAT and skeletal muscle is unrelated to insulin action in man [9].
###end p 6
###begin p 7
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Morosetti1">[13]</xref>
###xml 795 799 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 1022 1026 1018 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 824 829 <span type="species:ncbi:9606">human</span>
###xml 850 855 <span type="species:ncbi:10090">mouse</span>
###xml 990 995 <span type="species:ncbi:9606">human</span>
###xml 1073 1078 <span type="species:ncbi:9606">human</span>
###xml 1114 1120 <span type="species:ncbi:10090">murine</span>
Firm evidence of the similarity between mouse resistin like gamma, Retnlg/Xcp1, and human resistin, RETN/XCP1, was recently published by Chumakov et al.[12]. Interestingly, the expression of these genes was exclusively found in myeloid cells with the highest level in bone marrow. Their transcription is dependent on mouse Cebpe and human CEBPE [12]. The latter appears vital for terminal differentiation and functional maturation of human committed granulocyte progenitor cells [13]. In both species, this myeloid transcription factor was shown to be essential for, and co-expressed with, XCP1/RETN and Xcp1/Retnlg. Furthermore, its functional disruption in either species results in total silencing of RETN and Retnlg, whereas the induction triggers their expression even in non-myeloid cells [12]. Additionally, released human resistin as well as mouse resistin like gamma proteins play the same role in the chemotaxis of bone marrow-derived myeloid cells and specifically interact with human neutrophil alpha-defensin [12]. Taken together, these findings indicate that human RETN is the biological analogue of murine Retnlg.
###end p 7
###begin p 8
###xml 940 943 940 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Nagaev1">[9]</xref>
###xml 945 949 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Bokarewa1">[14]</xref>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
###xml 143 149 <span type="species:ncbi:10090">murine</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 490 495 <span type="species:ncbi:9606">human</span>
###xml 825 830 <span type="species:ncbi:9606">human</span>
###xml 835 840 <span type="species:ncbi:10090">mouse</span>
###xml 1013 1018 <span type="species:ncbi:9606">human</span>
This widely disregarded dualism of human resistin, i.e., RETN gene being a homologue of mouse Retn but a regulatory and functional analogue of murine Retnlg, has led to discrepant and controversial observations. All along, the mixed conception for human resistin as an adipocyte- and macrophage-derived cytokine with metabolic and inflammatory activities was a diffuse and confusing paradigm. As a result, none of the basic investigations and clinical trials could explicitly clarify which human cells produce resistin and its physiological role. Adding to the difficulty, resistin gene lineages have seemingly underwent various alterations during the evolution of different mammalian species. Therefore, in the present work, we tested all resistin regulatory, functional and also emerging evolutionary concepts in different human and mouse models aiming to explain the Resistin Paradox decisively. Overall, in addition to previous studies [9], [14], our new findings strongly support the immune-specific role of human resistin as a significant local and systemic modulator of inflammation.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 40 45 <span type="species:ncbi:9606">human</span>
Cell- and tissue-specific expression of human resistin
###end title 10
###begin p 11
###xml 336 343 336 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t002">Table 2</xref>
###xml 786 787 786 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 884 885 884 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1248 1256 1248 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1285 1292 1285 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t002">Table 2</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 69 75 <span type="species:ncbi:10090">murine</span>
###xml 251 256 <span type="species:ncbi:9606">human</span>
###xml 298 304 <span type="species:ncbi:10090">murine</span>
###xml 346 351 <span type="species:ncbi:9606">Human</span>
###xml 409 415 <span type="species:ncbi:10090">murine</span>
###xml 1352 1357 <span type="species:ncbi:9606">human</span>
We first examined if isolated human mature adipose cells, like their murine counterparts, express resistin and/or the necessary transcription factor CEBPE. For this purpose, we studied different leukocytic specimens as positive controls together with human WAT, preadipocytes and muscle as well as murine adipose cells and macrophages (Table 2). Human cells were tested for CEBPE and RETN as well as EMR1 (or murine alias F4/80), a leukocyte-specific receptor which indicates the presence of white blood cells in a sample. The transcription level of CEBPE was readily detectable and RETN was also expressed in freshly prepared PBMC and synoviocytes as well as in differentiated macrophages, albeit at a lower level. In these myeloid samples we observed a clear CEBPE-RETN correlation (R2 = 0.4, p<0.006, n = 9) and a lower, but still significant, association between CEBPE and EMR1 (R2 = 0.2, p<0.006, n = 9). In contrast, THP-1 monocytes displayed an apparent discrepancy with high expression of CEBPE but not of RETN. Also, PBMC cultured for 24 hours revealed a gradual decline in RETN transcription while the CEBPE mRNA level remained almost unchanged. After the culture period, the expression profiles in PBMC resembled that of THP-1 cells and in vitro differentiated macrophages (Table 2). Taken together, these results show that freshly isolated human primary inflammatory cells co-express CEBPE and RETN. However, RETN expression decreases during culture while CEBPE remains more stable.
###end p 11
###begin p 12
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 105 112 105 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t002">Table 2</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 483 488 <span type="species:ncbi:9606">human</span>
###xml 674 679 <span type="species:ncbi:9606">human</span>
###xml 816 821 <span type="species:ncbi:9606">human</span>
In some freshly obtained ex vivo human WAT specimens, CEBPE and RETN were detected with valid Ct values (Table 2). However, their expression was unrelated to fat depot, body mass index (BMI) or insulin resistance. Significantly, CEBPE and RETN mRNA were co-detected with the EMR1 transcript demonstrating that the expression of all these genes is limited to the myeloid cells present in a sample. This was further supported by the finding that homogeneous cell populations of either human preadipocytes or isolated subcutaneous adipocytes exhibited predominantly undetermined Ct for all these genes. Thus, the source of this low and variable expression of CEBPE and RETN in human WAT is likely to be blood leukocytes and/or resident macrophages - all EMR1-positive. Together, these results corroborate that isolated human primary adipocytes and preadipocytes do not express RETN or its transcriptional activator CEBPE.
###end p 12
###begin p 13
###xml 200 207 200 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t002">Table 2</xref>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
In contrast to these findings, Cebpe expression in mouse peritoneal macrophages was co-localized with Retnlg, but not with Retn transcription; the latter being solely restricted to adipose specimens (Table 2). The basis of such disparity between these two mammalian species, i.e., the differences seen between orthologous resistin genes, combined with the obvious similarity of non-homologous RETN and Retnlg, is presently unclear.
###end p 13
###begin title 14
Re-examination of RETN expression by specifically selected TaqMan real-time PCR assays
###end title 14
###begin p 15
###xml 453 460 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t003">Table 3</xref>
###xml 547 553 547 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">method</xref>
###xml 760 776 760 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">Table 4, Panel A</xref>
###xml 879 895 879 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">Table 4, Panel B</xref>
###xml 134 139 <span type="species:ncbi:9606">human</span>
It is important to clarify the reason for the controversial results produced by different authors regarding the expression of RETN in human adipose samples using the same real-time RT-PCR technique (see e.g., 9, 10 versus 11, 15, 16). Until recently, there was no inter-laboratory reference test available, but we have now compared one of three standard RETN Gene Expression Assays developed by Applied Biosystems with other resistin TaqMan constructs (Table 3) all-in-one-test. We purposely used the absolute quantification or the standard curve method because only this procedure firmly generates several key indices. The correlation coefficient represents the accuracy of the standard curve where a slope value around -3.5 means the highest PCR efficiency (Table 4, Panel A). Together, they indicate the reliability of each assay and also qualify the comparison between them (Table 4, Panel B).
###end p 15
###begin p 16
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">Table 4</xref>
###xml 295 302 295 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 307 314 307 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t003">Table 3</xref>
###xml 408 424 408 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">Table 4, Panel B</xref>
###xml 1323 1331 1323 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t002">Tables 2</xref>
###xml 1336 1337 1336 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">4</xref>
###xml 1170 1175 <span type="species:ncbi:9606">human</span>
###xml 1223 1231 <span type="species:ncbi:9606">patients</span>
In general, all three FAM/VIC multiplexed assays have similar detection effectiveness, while the fluctuations among Ct and slope numerals (Table 4) are mostly attributable to the differences in threshold and in ordinary set design including specific physico-chemical qualities of the probe (see Methods and Table 3). The data show that all assays are unable to detect RETN transcript in isolated adipocytes (Table 4, Panel B). Likewise, they cannot quantify it correctly in WAT and skeletal muscle even if Ct FAM values were determined. These values are within the invalid detection range from 35 to undetermined and significantly scattered in a replica in contrast to the consistent Ct figures in the blood and synovial samples. As a result, both inter-assay and intra-replica variations are small (6.5 and 4.7%) in the myeloid analyses versus the gross deviations (68 and 32%) in the adipose-muscle assessments. The intra-assay endogenous 18S rRNA control is also the inter-assay reference demonstrating a modest 8.4% divergence between all replicas, samples and assays. Thus, the complete uniformity of the trial confirms the low to absent detection level of RETN in human adipose tissue. In contrast, synoviocytes from patients with rheumatoid arthritis show that RETN expression is elevated at a site of inflammation (Tables 2 and 4).
###end p 16
###begin p 17
###xml 139 146 135 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t003">Table 3</xref>
We also investigated the potential expression of an alternatively spliced variant of RETN with deletion of the entire exon 3 (RETNDelta in Table 3) in the same one-plate-test. The copy number of this molecule was extremely low with an approximate ratio of 1:240 of the truncated vs. full-length transcripts. This was only possible to evaluate in PBMC (data not shown).
###end p 17
###begin p 18
###xml 156 162 156 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">method</xref>
###xml 335 340 <span type="species:ncbi:9606">human</span>
Altogether, these results demonstrate that neither alternative splicing nor variations between real-time PCR assays, but rather the high sensitivity of the method accounted for the detection of even a few RETN-positive leukocytes, either peripheral blood cells and/or the tissue-residing inflammatory cells, which were present in some human WAT samples.
###end p 18
###begin title 19
###xml 39 44 <span type="species:ncbi:9606">human</span>
Proinflammatory effects of resistin in human adipose tissue
###end title 19
###begin p 20
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Cinti1">[17]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Mazurek1">[18]</xref>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Bokarewa1">[14]</xref>
###xml 544 560 544 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000031-g001">Figure 1A (left)</xref>
###xml 868 884 868 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000031-g001">Figure 1A, right</xref>
###xml 1098 1113 1098 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000031-g001">Figure 1A, left</xref>
###xml 1284 1294 1284 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000031-g001">Figure. 1B</xref>
###xml 1613 1623 1613 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000031-g001">Figure. 1C</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 395 400 <span type="species:ncbi:9606">human</span>
###xml 1661 1666 <span type="species:ncbi:9606">human</span>
As concluded above, resistin is not expressed in human primary adipocytes but it is present in immune cells which are found in subcutaneous WAT in obesity [17] and also infiltrate epicardial fat depot in patients with coronary disease independent of BMI and diabetes [18]. Consequently, human adipocytes may be target cells for resistin. We investigated this possibility by exposing biopsies of human WAT to a physiologically relevant [14] concentration of resistin (50 ng/ml) or, as a positive control, 10 ng/ml of TNF for 24 hrs. As shown in Figure 1A (left), both cytokines induced expression of several inflammatory molecules, although to a different extent. TNF enhanced the expression of IL6 and IL8 79- and 44-fold, respectively, and its own gene about 3.4-fold. Similarly, secretion of both IL6 and IL8 to the culture medium was increased on average 28-times (Figure 1A, right). Resistin also elevated both the mRNA level (17- and 4-fold) and protein secretion (1.6- and 2.3-fold) of IL6 and IL8, while only a small (2.6-fold) and insignificant stimulatory effect was seen on the TNF gene (Figure 1A, left). Additionally, we found that resistin, similar to TNF, induces the CCL2, MMP3 and PBEF1 genes, which are all relevant to the inflammatory process in the adipose tissue (Figure. 1B). Although both TNF and RETN exerted a proinflammatory action on the WAT explants, their effects on the markers of adipose differentiation varied. As expected, TNF reduced the expression of CEBPA, FABP4 and SLC2A4 (GLUT4) by 40-70% while these genes remained unchanged upon exposure to resistin at this concentration (Figure. 1C). Together, these findings show that human adipocytes do not produce resistin but they are target cells for this cytokine which, in analogy with TNF, enhances the inflammatory process in adipose tissue.
###end p 20
###begin title 21
Discussion
###end title 21
###begin p 22
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Nagaev1">[9]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Savage1">[10]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Lu1">[19]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Ort1">[24]</xref>
###xml 258 264 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan2">[16]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan1">[15]</xref>
###xml 688 694 688 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-DegawaYamauchi1">[25]</xref>
###xml 855 861 855 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 861 865 861 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Janke1">[11]</xref>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 347 352 <span type="species:ncbi:9606">human</span>
###xml 661 664 <span type="species:ncbi:9606">man</span>
###xml 867 872 <span type="species:ncbi:9606">human</span>
Experimental human data regarding the nature of RETN-expressing cells as well as the physiological role of secreted resistin are controversial. In contrast to our own studies [9] and also those from several other laboratories [10], [12], [19]-[24], McTernan et al.[16] reported that resistin mRNA and protein could be recovered from both isolated human pre-adipocytes and mature adipose cells. Moreover, it was stated that RETN is differentially expressed between various fat depots [15]. In both studies, a higher signal was found in abdominal WAT suggesting that, similar to rodents, resistin may connect central obesity to insulin resistance and diabetes in man. Also, Degawa-Yamauchi et al.[25] detected RETN protein in isolated adipocytes and observed a positive association between serum resistin level and adiposity. Finally, in the study by Janke et al.[11], human preadipocyte differentiation was coupled with a declining gene expression. Although this observation was corroborated by barely measurable mRNA levels in primary cultured mature adipocytes, no link with insulin resistance was found.
###end p 22
###begin p 23
###xml 200 203 200 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Nagaev1">[9]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Savage1">[10]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Lu1">[19]</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Kaser1">[21]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Lehrke1">[26]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Curat1">[28]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Yang1">[22]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 642 645 642 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov1">[8]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Morosetti1">[13]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Antonson1">[29]</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Yamanaka1">[30]</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Patel1">[20]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Ort1">[24]</xref>
###xml 899 903 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 957 961 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Bokarewa1">[14]</xref>
###xml 981 985 981 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Lehrke1">[26]</xref>
###xml 1109 1113 1109 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Jung1">[27]</xref>
###xml 67 70 <span type="species:ncbi:9606">man</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
###xml 799 804 <span type="species:ncbi:9606">human</span>
In contrast to these discrepant results, various investigations in man consistently revealed the presence of resistin in myeloid cells: both primary monocyte-derived and/or differentiated macrophages [9], [10], [19]-[21], [26]-[28] as well as in primary acute leukemia cells and the myelocytic lines U937 and HL60 [22]. This leukocyte expression of human resistin was recently discovered to depend on the myeloid-specific nuclear transcription factor CEBPE [12]. The action of CEBPE was previously known to be restricted to the haematopoietic tissues, especially myeloid granulocyte/macrophage and lymphoid T-cell lineages in the bone marrow [8], [13], [29], [30]. In line with, but independent of the CEBPE research, the highest level of resistin was found in the bone marrow [20], [24]. Moreover, human resistin possesses diverse immune activities such as induction of chemotaxis of myeloid cells [12], as an inflammatory cytokine in rheumatoid arthritis [14] and in endotoxemia [26], and as a macrophage-derived atherogenic factor inducing endothelial dysfunction and vascular smooth muscle cell migration [27].
###end p 23
###begin p 24
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Yang1">[22]</xref>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Dai1">[31]</xref>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Dai1">[31]</xref>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chen1">[32]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Bokarewa1">[14]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Kawanami1">[33]</xref>
###xml 741 745 741 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Burnett1">[34]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
###xml 482 485 <span type="species:ncbi:9913">cow</span>
###xml 490 493 <span type="species:ncbi:9823">pig</span>
###xml 645 650 <span type="species:ncbi:10090">mouse</span>
###xml 655 660 <span type="species:ncbi:9606">human</span>
Human RETN and mouse Retn genes are orthologs [22] and, consequently, due to their evolutionary genetic relatedness, thought to be homologous traits. Surprisingly, human resistin exhibits characteristics which are clearly distinct from those of its mouse counterpart Retn. Furthermore, RETN shares prominent similarity with Retnlg [12], another resistin family member identified only in rodents. This still unrecognized phenomenon took place during evolution of other mammals, like cow and pig, also expressing RETN in myeloid cells [31] rather than in adipose tissue [31], [32]. The current understanding of this discrepancy is difficult since mouse and human resistin, nevertheless, exhibit common arthritogenic [14] and atherogenic [33], [34] features even if they are produced by different cells.
###end p 24
###begin p 25
###xml 220 226 220 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t002">Table 2</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Khazen1">[35]</xref>
###xml 810 817 810 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 849 857 849 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1172 1176 1172 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 1178 1182 1178 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Morosetti1">[13]</xref>
###xml 1263 1267 1263 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Morosetti1">[13]</xref>
###xml 1335 1342 1335 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t002">Table 2</xref>
###xml 1425 1429 1425 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 1484 1488 1484 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Williamson1">[36]</xref>
###xml 1542 1546 1542 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chih1">[37]</xref>
###xml 1588 1592 1588 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 1641 1645 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Patel1">[20]</xref>
###xml 1659 1663 1659 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Osawa1">[38]</xref>
###xml 1680 1684 1680 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Seo1">[39]</xref>
###xml 1722 1730 1722 1730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1828 1832 1828 1832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Morosetti1">[13]</xref>
###xml 1956 1963 1956 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t002">Table 2</xref>
###xml 2149 2156 2149 2156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 53 58 <span type="species:ncbi:9606">human</span>
In the present study, we carefully examined in which human cells resistin is expressed and also focused on the CEBPE-RETN transcriptional link and the putative immune/inflammatory action in WAT. Consistent with Chumakov et al.[12], we found that RETN generally follows CEBPE expression. Both transcripts were also determined to be attributes of myeloid cells because of the stringent co-localization with EMR1, which appeared to be a common leukocytic marker (Table 2) rather than an exclusive macrophage determinant [35]. Therefore, it is essential to further define the precise mechanism of RETN expression in particular types of leukocytes present in blood and synovia as well as in adipose tissue. We observed a clear discrepancy in expression of the RETN and CEBPE genes in myeloid samples newly obtained in vivo vs. the same cells conditioned in vitro. There was a high and concomitant CEBPE-RETN expression in fresh blood and synovial fluid specimens but a reduced and dissociated transcription in cultured PBMC, macrophages and THP-1 cells. The latter immortalized cells do not express RETN but visibly display CEBPE as also corroborated by Northern blot analysis [12], [13]. Nonetheless, very low CEBPE expression in macrophages, seen here and by others [13], was yet accompanied by RETN transcription, albeit at a low level (Table 2). Although the RETN expression is under ultimate transcriptional control of CEBPE [12], the activity of CEBPE is modified by phosphorylation [36], heterodimerization with abundant associate proteins [37] and a synergistic effect of MYB and ATF4 [12]. Other transcriptional factors, like PPAR gamma [20], SP1 and SP3 [38] and also SREBF1 [39], could influence the RETN regulation in vitro. The role and activation of CEBPE is different during granulocytic and monocytic differentiation [13]. Consequently, CEBPE-to-RETN regulatory strength can change considerably upon various conditions and in certain cell type (Table 2). Our results show a higher expression level of both genes in synoviocytes, presumably granulocytes, than in peripheral monocytes as well as a maintained CEBPE-RETN proportion in these ex vivo models.
###end p 25
###begin p 26
###xml 90 98 90 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t002">Tables 2</xref>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">4</xref>
###xml 210 213 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Nagaev1">[9]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Savage1">[10]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Lu1">[19]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Ort1">[24]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Jung1">[27]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Curat1">[28]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Curat1">[28]</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Fain1">[40]</xref>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
Importantly, human preadipocytes and isolated fat cells were clearly devoid of RETN mRNA (Tables 2 and 4), similar to endothelial cells, smooth muscle and many other non-myeloid tissues, which have been tested [9], [10], [12], [19]-[24], [27], [28]. Furthermore, the resistin release by adipose tissue is not due to adipose cells [28], [40]. Together, these data suggest that human resistin should not be acknowledged as an adipose-secreted hormone but as a specific myeloid-derived cytokine.
###end p 26
###begin p 27
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 262 265 262 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Gerstmayer1">[5]</xref>
###xml 266 269 266 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Kubota1">[7]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 494 498 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Chumakov2">[12]</xref>
###xml 630 637 630 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t001">Table 1</xref>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Shojima1">[41]</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Bokarewa1">[14]</xref>
###xml 20 26 <span type="species:ncbi:10090">murine</span>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 321 326 <span type="species:ncbi:10090">mouse</span>
###xml 442 447 <span type="species:ncbi:9606">human</span>
###xml 581 587 <span type="species:ncbi:10090">murine</span>
###xml 616 621 <span type="species:ncbi:9606">human</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
We also studied the murine genes Cebpe, Retn and Retnlg, because the latter was found as a regulatory and functional equivalent of human RETN [12]. Only Retn was detected in adipose tissue of ob/ob mice and 3T3-L1 cells, whereas, in agreement with other results [5]-[7], [12], Cebpe and Retnlg expression was observed in mouse peritoneal macrophages. However, very little is known about similarities and differences between rodent Retnlg and human RETN since only one study exists in the field [12]. Obviously, lack of recognition of this fact is the basis of a recent proposal of murine Retnlg and the non-existent human RETNLG (Table 1) as a hormonal link between the digestive tract and insulin resistance in both species [41]. Such conclusions only create confusion. Also a presumed arthritogenic Retn-Retnlg cross-function in mice [14] needs a further clarification.
###end p 27
###begin p 28
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Korner1">[23]</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Ort1">[24]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Yang1">[22]</xref>
###xml 494 501 494 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t003">Table 3</xref>
###xml 628 635 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">Table 4</xref>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan1">[15]</xref>
###xml 756 760 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan2">[16]</xref>
###xml 834 841 834 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t003">Table 3</xref>
###xml 905 912 905 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">Table 4</xref>
###xml 1163 1164 1163 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1175 1182 1175 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">Table 4</xref>
###xml 1242 1248 1242 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1248 1252 1248 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan1">[15]</xref>
###xml 1254 1258 1254 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan2">[16]</xref>
###xml 1260 1264 1260 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan3">[42]</xref>
###xml 1266 1270 1266 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Baker1">[43]</xref>
###xml 1568 1572 1568 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan1">[15]</xref>
###xml 1574 1578 1574 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan2">[16]</xref>
###xml 1580 1584 1580 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan3">[42]</xref>
###xml 1586 1590 1586 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Baker1">[43]</xref>
###xml 733 738 <span type="species:ncbi:9606">human</span>
###xml 1650 1655 <span type="species:ncbi:9606">human</span>
Despite many RETN mRNA evaluations by real-time PCR, different problems related to bioinformatic errors and test designs exist [23], [24]. In addition, conflicting Northern and SYBR Green RT-PCR results [22] and lack of initial Ct values in most reports make firm conclusions impossible. With the aim of having a gene expression analysis as decisive as possible, we included the impartial inter-laboratory reference TaqMan RT-PCR assays from Applied Biosystems in parallel to our custom tests (Table 3). They all demonstrated comparable outcomes over the entire investigation also in the single-shot trial of three RETN assays (Table 4), including the one that was reported to be successful in the quantification of resistin mRNA in human adipocytes [15], [16]. All three constructs detect a common sequence in full-length RETN mRNA (Table 3) and the multiplexed assays have similar detection efficiency (Table 4). A higher level of RETN transcript was detected in inflamed synoviocytes in comparison to normal PBMC. In contrast, no valid quantification could be made in adipose and muscle samples by any of these optimized tests, as indicated by both slope and R2 values in Table 4. To obtain a RETN signal in the adipose analysis, McTernan et al.[15], [16], [42], [43] overloaded the cDNA to 115 ng in which a proportion of 18S ribosomal RNA cannot be linearly distinguished and, hence, the Ct of the internal reference can not normalize the Ct of the tested gene. Under these conditions, the dCt figures and the final quantity evaluations are, at best, conjectural [15], [16], [42], [43]. Taken together, we conclude that RETN is not expressed in human isolated fat cells and that reports claiming positive results have methodological shortcomings which have led to spurious conclusions.
###end p 28
###begin p 29
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Curat1">[28]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Ort1">[24]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Bokarewa1">[14]</xref>
###xml 1051 1055 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Ort1">[24]</xref>
###xml 1075 1081 1075 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1081 1085 1081 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-McTernan3">[42]</xref>
###xml 598 603 <span type="species:ncbi:9606">human</span>
###xml 944 949 <span type="species:ncbi:9606">human</span>
A proinflammatory nature of resistin has been suggested, but its precise action in hepatocytes [28] and adipose tissue [24] is unclear. We previously noticed that, in PBMC, resistin can induce both gene expression and secretion of inflammatory cytokines like IL6, IL8 and TNF of which only TNF, but not resistin, rapidly up-regulates RETN [14]. Interestingly, lipopolysaccharide, a bacterial endotoxin, controls RETN in the same, presumably TNF-mediated, manner (unpublished data). Here we demonstrate that, like in PBMC, resistin can also enhance the gene and protein expression of IL6 and IL8 in human WAT, while the effect on TNF mRNA expression was small. However, in contrast to the well-known TNF-induced suppression of different adipose-specific markers such as CEBPA, FABP4 and SLC2A4, these genes were not affected by resistin at the concentration of 50 ng/ml. These data concur with the unchanged insulin-stimulated glucose uptake by human differentiated adipocytes treated with high concentrations of recombinant resistin (58.5-5850 ng/ml) [24]. However, McTernan et al.[42] reported that 0.1-50 ng of resistin impaired the glucose incorporation into adipocytes. The cause for this discrepancy is unclear.
###end p 29
###begin p 30
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Bokarewa1">[14]</xref>
###xml 84 89 <span type="species:ncbi:9606">human</span>
We also found that resistin, similar to TNF, induces other proinflammatory genes in human adipose tissue. Chemokine C-C motif ligand 2 (CCL2) is a cytokine that displays chemotactic activity for monocytes. Matrix metallopeptidase 3 (MMP3) may affect the extracellular milieu of adipose tissue akin to that in arthritis. Also PBEF1, pre-B-cell colony enhancing factor 1 or visfatin, was activated by these cytokines. Both the basal and resistin-stimulated gene expression profiles in WAT cultures bear a remarkable resemblance to that seen in PBMC [14], but with clear cell-type differences.
###end p 30
###begin p 31
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 279 282 <span type="species:ncbi:9606">man</span>
In conclusion, human fat cells do not express or secrete RETN but WAT is evidently a target tissue for resistin. This finding, together with the effect of resistin on PBMC, makes it clear that resistin is an immune-derived systemic and locally acting proinflammatory cytokine in man. However, in contrast to TNF, it does not induce a rapid "dedifferentiation" of the adipose cells. This variation is intriguing and obviously implicates that the resistin intracellular signaling pathway is distinct from that of TNF although both activate NFkappaB.
###end p 31
###begin title 32
Materials and Methods
###end title 32
###begin title 33
Source of RNA and culture procedures
###end title 33
###begin p 34
###xml 570 574 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Sopasakis1">[44]</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 480 485 <span type="species:ncbi:9606">human</span>
###xml 645 650 <span type="species:ncbi:9606">human</span>
All biopsy procedures were approved by the Ethical Committee of the Goteborg University. Biopsies of human abdominal subcutaneous adipose tissue were obtained from surgical operations for nonsystemic abdominal disorders (mainly uterine extirpation, gall bladder disease) from seven otherwise healthy and nonobese females (BMI 26.1+/-1.8 kg/m2). The biopsies were cleaned of blood and tissue debris, dissected into 10-20 mg explants and incubated in medium 199 HANKS containing 1% human albumin, 10mM HEPES, and 5.6 mM glucose according to previously reported procedures [44]. WAT explants were cultured with 10 ng/ml TNF (Sigma, UK) or 50 ng/ml human recombinant RETN (PeproTech EC, UK) or without additives for 24 h. The medium concentrations of the different cytokines were measured with ELISA (R&D Systems, Minneapolis, MN, USA and BioVendor, Czech Republic).
###end p 34
###begin p 35
###xml 436 440 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Bokarewa1">[14]</xref>
###xml 1198 1201 1196 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Nagaev1">[9]</xref>
###xml 1203 1207 1201 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Sopasakis1">[44]</xref>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
###xml 917 922 <span type="species:ncbi:9606">human</span>
###xml 989 995 <span type="species:ncbi:10090">Murine</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
###xml 1074 1079 <span type="species:ncbi:9606">human</span>
###xml 1144 1149 <span type="species:ncbi:10090">mouse</span>
Preadipocytes were also obtained from the stromal vascular fraction of biopsies of the abdominal subcutaneous WAT of non-obese individuals. Another set of both omental and subcutaneous adipose tissue biopsies were collected during surgical excision of non-disseminated gastrointestinal cancers from 9 individuals (BMI 26.0+/-1.2 kg/m2) for the extraction of total RNA. PBMC were isolated and stimulated by resistin and LPS as described [14]. The PBMC fraction from a Lymphoprep density gradient consists of mononuclear leukocytes, lymphocytes and less than 1% of polymorphonuclear granulocytes. Synovial fluids from patients with rheumatoid arthritis were centrifuged at 3000xg for 10 minutes to pool monocytes, granulocytes, fibroblasts and other cells collectively called synoviocytes. The monocytic cell line, THP-1, was used as a standard of CEBPE, RETN and EMR1 gene expression at basal conditions. The RNA from human macrophages was kindly provided by Dr. B. Staels (Lille, France). Murine macrophages were acquired from peritoneal exudates of BALB-C mice. Additional human skeletal muscle and isolated mature adipocytes, also 3T3-L1 and mouse WAT samples have been explained in past studies [9], [44].
###end p 35
###begin title 36
Real-time RT-PCR
###end title 36
###begin p 37
###xml 410 413 410 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Nagaev1">[9]</xref>
###xml 924 927 908 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000031-Nagaev1">[9]</xref>
###xml 1079 1086 1063 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t003">Table 3</xref>
###xml 1462 1469 1437 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t003">Table 3</xref>
All cellular samples were immediately subjected to the lysis buffer and further processed with RNA extraction according to the RNeasy Mini Kit manual (Qiagen, UK). Tissue specimens were placed in RNA Later (Ambion, Austin, TX, USA) prior to a cell disintegration by guanidinium thiocyanate followed by chloroform extraction and final RNA purification via CsCl gradient ultracentrifugation as described earlier [9]. Total RNA was obtained from tissue and cell samples before and after culture. RNA concentration and lambda 260/280 nm ratio was assessed and complementary DNA synthesized according to the TaqMan(R) Reverse Transcription Reagents kit manual (Applied Biosystems, Foster City, CA, USA) and loaded in each well at an amount approximately equal to 5 ng total RNA. The gene expression was measured with real-time RT-PCR (TaqMantrade mark, Applied Biosystems, Foster City, CA, USA) as previously described in detail [9]. Each custom TaqMan set, if possible, spans one or two exon boundaries in order to facilitate both specificity of RNA detection and efficiency of PCR (Table 3). Sequences were manually designed and checked by means of the PrimerExpresstrade mark program (Applied Biosystems) for the following parameters: secondary structure, melting temperature, GC content, primer-primer and primer-probe dimers. The NCBI GenBank database was used to avoid all known sites of nucleotide polymorphism and unspecific annealing of any oligonucleotide. Table 3 shows the PCR primer positions in source mRNA sequences, which are close to the exon junctions we used in our design. The indicated location in the TaqMan(R) Gene Expression Assay from Applied Biosystems is exon boundary which is typically situated around the middle of the TaqMan probe. Our custom sequences are available on request.
###end p 37
###begin p 38
###xml 650 658 648 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">method's</xref>
###xml 732 748 730 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t004">Table 4, Panel A</xref>
###xml 1407 1414 1390 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
The real-time PCR tests were run as multiplexed, with simultaneous detection in each well of both target transcript and 18S rRNA, an eukaryotic endogenous control, obtainable as TaqMan(R) Pre-Developed Assay Reagents (PDAR) for Gene Expression, Applied Biosystems. Due to over 90% abundance of 18S rRNA in total cell RNA, the 18S rRNA PDAR has the primer concentration limited from ordinary 900 nM to 150 nM with the aim to delay very early amplification and to balance two parallel polymerase chain reactions in a multiplexed assay. Nevertheless, as small amounts of total RNA as 1-5 ng produce "premature", lesser 15, Ct values that are within the method's default background interval from cycle 3 to 15. Therefore, we optimized (Table 4, Panel A) two PDARs specifically pre-mixed as reporter VIC(R) dye-labeled TaqMan(R), either; 1) non-fluorescent quencher MGB, for minor groove binding, or; 2) fluorescent quencher TAMRAtrade mark probes, each at restricted concentration 50 nM, with a pair of unlabeled PCR primers, each further limited to 30 nM in the reaction. The PDARs were, respectively, combined with; 1) TaqMan(R) Gene Expression Assay at the concentration of 250 nM for FAM-MGB probe and 900 nM of each primer, and; 2) custom constructs formulated as reporter FAM dye-labeled TAMRA dye-quencher probe at 200 nM and both primers at 400 nM final concentration. Comparative Ct and standard curve methods were applied in that order for relative and absolute quantifications but all results were presented as a fold change over the reference level assessed as 1 or 100%.
###end p 38
###begin p 39
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Statistical analyses</italic>
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical analyses were carried out with Student's t-test and P-values of <0.05 were considered significant.
###end p 39
###begin p 40
###xml 41 43 41 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
Part of this data was presented at the 41st Annual Meeting of the European Association for the Study of Diabetes in Athens, Greece 2005, and has been published as an Abstract to that meeting.
###end p 40
###begin title 41
References
###end title 41
###begin article-title 42
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family.
###end article-title 42
###begin article-title 43
A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation.
###end article-title 43
###begin article-title 44
The hormone resistin links obesity to diabetes.
###end article-title 44
###begin article-title 45
A family of tissue-specific resistin like molecules.
###end article-title 45
###begin article-title 46
Identification of RELMgamma, a novel resistin like molecule with a distinct expression pattern.
###end article-title 46
###begin article-title 47
Cloning and functional characterization of resistin like molecule gamma.
###end article-title 47
###begin article-title 48
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Representational difference analysis using myeloid cells from C/EBP epsilon deletional mice.
###end article-title 48
###begin article-title 49
###xml 21 26 <span type="species:ncbi:9606">human</span>
Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor.
###end article-title 49
###begin article-title 50
###xml 81 86 <span type="species:ncbi:9606">human</span>
Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle.
###end article-title 50
###begin article-title 51
###xml 112 118 <span type="species:ncbi:9606">humans</span>
Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.
###end article-title 51
###begin article-title 52
###xml 28 33 <span type="species:ncbi:9606">human</span>
Resistin gene expression in human adipocytes is not related to insulin resistance.
###end article-title 52
###begin article-title 53
###xml 18 24 <span type="species:ncbi:10090">murine</span>
###xml 29 34 <span type="species:ncbi:9606">human</span>
Identification of murine and human XCP1 genes as C/EBP-epsilon-dependent members of FIZZ/Resistin gene family.
###end article-title 53
###begin article-title 54
A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation.
###end article-title 54
###begin article-title 55
Resistin, an Adipokine with Potent Proinflammatory Properties.
###end article-title 55
###begin article-title 56
Resistin, central obesity, and type 2 diabetes.
###end article-title 56
###begin article-title 57
###xml 50 55 <span type="species:ncbi:9606">human</span>
Increased resistin gene and protein expression in human abdominal adipose tissue.
###end article-title 57
###begin article-title 58
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 97 103 <span type="species:ncbi:9606">humans</span>
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.
###end article-title 58
###begin article-title 59
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human epicardial adipose tissue is a source of inflammatory mediators.
###end article-title 59
###begin article-title 60
Lipopolysaccharide increases resistin gene expression in vivo and in vitro.
###end article-title 60
###begin article-title 61
###xml 25 30 <span type="species:ncbi:9606">human</span>
Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.
###end article-title 61
###begin article-title 62
Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.
###end article-title 62
###begin article-title 63
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Comparative studies of resistin expression and phylogenomics in human and mouse.
###end article-title 63
###begin article-title 64
###xml 26 32 <span type="species:ncbi:9606">humans</span>
Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight.
###end article-title 64
###begin article-title 65
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
Recombinant human FIZZ3/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice.
###end article-title 65
###begin article-title 66
###xml 53 59 <span type="species:ncbi:9606">humans</span>
Serum resistin (FIZZ3) protein is increased in obese humans.
###end article-title 66
###begin article-title 67
###xml 56 62 <span type="species:ncbi:9606">Humans</span>
An Inflammatory Cascade Leading to Hyperresistinemia in Humans.
###end article-title 67
###begin article-title 68
Resistin is secreted from macrophages in atheromas and promotes atherosclerosis.
###end article-title 68
###begin article-title 69
###xml 15 20 <span type="species:ncbi:9606">human</span>
Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin.
###end article-title 69
###begin article-title 70
###xml 8 13 <span type="species:ncbi:9606">human</span>
A novel human CCAAT/enhancer binding protein gene, C/EBPepsilon, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor alpha/delta locus.
###end article-title 70
###begin article-title 71
CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing.
###end article-title 71
###begin article-title 72
Cloning and characterization of porcine resistin gene.
###end article-title 72
###begin article-title 73
###xml 69 72 <span type="species:ncbi:9823">pig</span>
Increased expression of resistin and tumour necrosis factor-alpha in pig adipose tissue as well as effect of feeding treatment on resistin and cAMP pathway
###end article-title 73
###begin article-title 74
Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions.
###end article-title 74
###begin article-title 75
The potential role of resistin in atherogenesis.
###end article-title 75
###begin article-title 76
###xml 46 51 <span type="species:ncbi:9606">human</span>
Expression of macrophage-selective markers in human and rodent adipocytes.
###end article-title 76
###begin article-title 77
CCAAT/enhancer binding protein epsilon: changes in function upon phosphorylation by p38 MAP kinase.
###end article-title 77
###begin article-title 78
Protein partners of C/EBPepsilon.
###end article-title 78
###begin article-title 79
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.
###end article-title 79
###begin article-title 80
###xml 35 40 <span type="species:ncbi:9606">human</span>
Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha.
###end article-title 80
###begin article-title 81
###xml 20 25 <span type="species:ncbi:9606">human</span>
Resistin release by human adipose tissue explants in primary culture.
###end article-title 81
###begin article-title 82
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Serum concentrations of resistin like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow.
###end article-title 82
###begin article-title 83
###xml 168 173 <span type="species:ncbi:9606">human</span>
Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.
###end article-title 84
###begin article-title 85
Cytokine release from adipose tissue of nonobese individuals.
###end article-title 85
###begin article-title 86
###xml 107 112 <span type="species:ncbi:9606">human</span>
Identification of an alternative splicing transcript for the resistin gene and distribution of its mRNA in human tissue.
###end article-title 86
###begin title 87
Figures and Tables
###end title 87
###begin title 88
###xml 56 61 <span type="species:ncbi:9606">Human</span>
Resistin Preferentially Induces Inflammatory Markers in Human WAT.
###end title 88
###begin p 89
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human WAT explants were incubated with 10 ng/ml TNF, white bars, or 50 ng/ml resistin, grey bars, for 24 hrs and the fold change for several markers assessed by comparison with their level in basal cultures after 24 hrs.
###end p 89
###begin p 90
###xml 3 4 3 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 3 4 3 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>A</italic></bold>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>B</italic></bold>
In A both gene (left) and protein (right) expressions of proinflammatory cytokines are shown, while B represents other inflammation-related effects in WAT.
###end p 90
###begin p 91
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>C</italic></bold>
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
C demonstrates different effects of TNF and resistin on markers of adipocyte differentiation. *, P<0.1; **, P<0.01; ***, P<0.001.
###end p 91
###begin title 92
###xml 36 48 36 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 50 52 50 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mm</italic>
###xml 58 70 58 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 72 74 72 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hs</italic>
###xml 36 48 <span type="species:ncbi:10090">Mus musculus</span>
###xml 58 70 <span type="species:ncbi:9606">Homo sapiens</span>
Different Resistin Gene Families in Mus musculus (Mm) and Homo sapiens (Hs)
###end title 92
###begin p 93
###xml 71 78 71 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in bold</bold>
To avoid variant readings of any gene only official symbols and names (in bold) with species-specific spellings as provided by the HUGO Gene Nomenclature Committee and the NCBI are operated in this work together with other aliases when appropriate.
###end p 93
###begin p 94
###xml 301 303 301 303 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">70</underline>
###xml 304 306 304 306 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">74</underline>
This alias is unpublished discovery of resistin gene family by Rajala MW and Scherer PE with proposal titles as Identification of a novel adipose-specific cysteine-rich secreted protein & Identification of a novel cysteine-rich secreted A12-alpha related protein was supported by five sequences AF290870-74 submitted to the NCBI (28-JUL-2000).
###end p 94
###begin title 95
Examination of Gene Expression in Basally Conditioned Tissue and Cell Cultures
###end title 95
###begin p 96
###xml 258 263 <span type="species:ncbi:9606">human</span>
The lower the expression, the higher the threshold cycle (Ct) value excluding the invalid detection range from 35 and up to undetermined (UD) Ct if no amplification occurs within 40 cycles. As a result, the expression of tested genes cannot be quantified in human adipose and muscle samples and this part of the data simply shown as indicative Ct intervals obtained in different experiments. Conversely, the operable Ct figures in myeloid/synovial group were evaluated as relative quantities (RQ) with the reference PBMC settings as 1 or 100%.
###end p 96
###begin title 97
Common Principle of the Over-Exon-Boundary Location of Probe in Reference Gene Expression Assays (GEA) and Primer(s) in our Custom Tests
###end title 97
###begin p 98
Description of three RETN custom tests: 1) primers in our previous RSTN set (9) overlap two consequent exon-exon junctions, which separately spanned by different probes in 2) RES, a custom construct from another laboratory (15), and in standard RETN GEA from Applied Biosystems; finally, 3) RETN? is our design for the deletion variant of RETN mRNA (45).
###end p 98
###begin p 99
5'-end of the probe.
###end p 99
###begin p 100
The standard and custom constructs detect both currently known transcript variants of PBEF1.
###end p 100
###begin p 101
The assay location is not at exon junction because CEBPA is an intronless gene.
###end p 101
###begin title 102
Special Evaluation of Different RETN TaqMan Assays by Absolute (AQ) and Relative (RQ) Quantification Analyses
###end title 102
###begin p 103
###xml 5 13 5 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Panels A</italic>
###xml 5 13 5 13 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Panels A</italic></bold>
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 18 19 18 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>B</italic></bold>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 93 94 93 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>A</italic></bold>
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 109 110 109 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>B</italic></bold>
###xml 374 381 374 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000031-t003">Table 3</xref>
Both Panels A and B are derived from the one-plate-test performed in replicas which shown in A distinct from B as an interchange of shadow and clear lines. Clarification of acronyms: Ct, cycle of threshold; FAM, reporter dye in RETN detections; VIC, reporter dye in 18S rRNA endogenous control detections; UD, undetermined Ct; Resistin assays RSTN, RES and GEA explained in Table 3.
###end p 103
###begin p 104
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Panel A</italic>
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Panel A</italic></bold>
Panel A shows original Ct values in STND, standard nanogram quantity, titrations and consequent standard curve parameters: Slope, cycles/log decade, and R2, correlation coefficient. The NTC, no template control, indicates the specificity of detection. The nature of low but persistent signal in 18S rRNA NTC detections is uncertain. Nevertheless, this is definitely not a DNA contamination, because the "pollutant" amplification plots and Ct values along with resulting absolute quantities - all disagree with those in the standard curve assessments. Importantly, this undesirable non-specific signal affects even the nearest STDN-0.1 ng titrations as little as 0.141, 0.013 and 0.009% in corresponding RETN assays.
###end p 104
###begin p 105
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Panel B</italic>
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Panel B</italic></bold>
###xml 186 193 186 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AQ Mean</bold>
###xml 302 324 302 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN-Comparative AQ/RQ</bold>
###xml 339 346 339 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 845 851 845 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">method</xref>
Panel B represents original Ct values and both absolute (AQ) and relative (RQ) quantity evaluations of RETN transcript in six demonstrative samples. In each replica, further derivatives AQ Mean and AQ StdDev, standard deviation, were produced automatically by the program, while RETN-Normalized AQ and RETN-Comparative AQ/RQ manually. The methods execute different equations, but the same normalization by 18S rRNA endogenous control. The final results were evaluated as Comparative AQ = (Normalized AQ Sample)/(Normalized AQ PBMC), where Normalized AQ = (AQ Mean-RETN)/(AQ Mean-18S rRNA); as well as Comparative RQ = 2(-ddCt), where ddCt = (dCt Sample)-(dCt PBMC) and dCt = (Ct FAM)-(Ct VIC). All Comparative quantities are proportional to the reference PBMC quantity assigned as 1 or 100%. Notably, they are independent of the quantification method due to both RETN and 18S rRNA slope values in each individual assay are around optimal -3.5 and/or comparable. Finally, for every particular sample, the inter-assay AQ Mean-18S rRNA figures are consistent, that ultimately signifies the equal load and, hence, the true low to absent RETN mRNA content in the adipose/muscle tissues.
###end p 105
###begin p 106
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 106
###begin p 107
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The Swedish Research Council (K 2004-72x-03506-33A, K2004-74P-15176-01A, K2004-06X-08674-16A), the European Community's FP6 EUGENE2 (LSHM-CT-2004-512013), the Swedish Diabetes Association, the Novo Nordisk Foundation, the Torsten and Ragnar Soderberg's Foundation, National Inflammation Network, Swedish Association against Rheumatism, King Gustaf V's Foundation, Nanna Svartz's Foundation, Goteborg Medical Society, Borje Dahlin's Foundation, and the Goteborg University.
###end p 107

